Fluorouracil is also called as FU or 5FU and is one of the most commonly used drugs to treat cancer. It is part of a group of chemotherapy drugs known as anti-metabolites. Anti-metabolites are like normal body molecules but they have a slightly different structure. Fluorouracil (5FU) can cause side effects but these can affect everyone differently such as increased risk of infection, Anaemia (low level of red blood cells), Nosebleeds, Loss of appetite and other. Rising incidence and prevalence of various cancer types and growing concerns over high death rates due to cancer are the major factors boosting the global fluorouracil (5FU) marketThis growth is primarily driven by Rising incidence and prevalence of various cancer types and Rise in need for R&D activities in cancer.
Globally, a noticeable market trend is evident Growing concerns over high death rates due to cancer. The Pharmaceuticals sector in the North America region has been increasing at a strong rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as NPS MedicineWise (Australia), Taj Pharmaceuticals Limited (India), Celon Labs (India), Shree Ganesh Rubber & Chemicals Co (India), Mylan N.V. (United States), Chandra Bhagat Pharma Pvt. Ltd. (India), Neon Laboratories Ltd (India), Mayne Pharma (Australia), Glaxo Smithkline Pharmaceuticals Ltd. (India) and Dabur Pharmaceuticals Ltd. (India) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On 23 July, 2018, Mayne Pharma today announce that it has completed the acquisition of generic Efudex (fluorouracil cream 5%) from Spear Pharmaceuticals, Inc.
- Rising incidence and prevalence of various cancer types
- Rise in need for R&D activities in cancer
- Growing concerns over high death rates due to cancer
- Adverse effects of anti-cancer drugs
Advancement of anti-cancer drugs research
High cost of drug development and threat of failure
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase